Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 1626-1630, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (71)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoon, Y.
Right arrow Articles by Kim, J. Q
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, Y.
Right arrow Articles by Kim, J. Q
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2000;46:1626-1630.)
© 2000 American Association for Clinical Chemistry, Inc.


Articles

Plasma Nitric Oxide Concentrations and Nitric Oxide Synthase Gene Polymorphisms in Coronary Artery Disease

Yeomin Yoon1, Junghan Song1, Seung Ho Hong1 and Jin Q Kima,1

1 Department of Clinical Pathology, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-799, Korea.
a Author for correspondence. Fax 82-2-745-6653; e-mail jqkim{at}plaza.snu.ac.kr

Background: Plasma NOx (nitrate and nitrite) is a stable end product of the vasodilator NO. Several polymorphisms in the endothelial constitutive NO synthase (ecNOS) gene have been reported, including the 4a/4b VNTR polymorphism in intron 4, the E298D mutation in exon 7, and the G10-T polymorphism in intron 23. The aims of this study were to examine plasma NOx in patients with coronary artery disease (CAD) and to assess the association between plasma NOx concentrations and the three ecNOS gene polymorphisms.

Methods: Plasma NOx was measured in samples from 128 healthy controls and from 110 CAD patients at least 2 months after myocardial infarction. Three genetic polymorphisms that are known or have been suggested to be associated with plasma NOx concentration were also analyzed by PCR-restriction fragment length polymorphism.

Results: Median plasma NOx was significantly higher (P <0.001) in CAD patients (95.9 µmol/L) than in controls (73.8 µmol/L). Furthermore, the median plasma NOx was significantly higher (P <0.001) in hypertensive CAD patients (116.0 µmol/L) than in controls and normotensive CAD patients (86.0 µmol/L). The G-allele frequency of the G10-T polymorphism in intron 23 was significantly higher in CAD patients than in controls. Other polymorphisms showed no differences in allelic frequencies among the control and CAD groups. In controls, individuals with the E298D mutation in exon 7 (136.1 µmol/L) showed significantly higher (P = 0.001) median plasma NOx than those without this mutation (64.5 µmol/L).

Conclusions: Plasma NOx was higher in hypertensive CAD patients than in normotensive CAD patients and controls. The E298D polymorphism of the ecNOS gene was associated with increased plasma NOx. Further study is needed to understand the gene expression and enzyme activity of ecNOS and their association with genotypes.




The following articles in journals at HighWire Press have cited this article:


Home page
ANGIOLOGYHome page
A. Gluba, M. Banach, J. Rysz, G. Piotrowski, W. Fendler, and T. Pietrucha
Is Polymorphism Within eNOS Gene Associated With the Late Onset of Myocardial Infarction? A Pilot Study
Angiology, October 1, 2009; 60(5): 588 - 595.
[Abstract] [PDF]


Home page
Hum ReprodHome page
H. Kim, S. Y. Ku, S. H. Kim, G. H. Lee, Y. M. Choi, J. M. Kim, T. H. Lee, and S. Y. Moon
Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with advanced stage endometriosis
Hum. Reprod., October 1, 2009; 24(10): 2656 - 2659.
[Abstract] [Full Text] [PDF]


Home page
In VivoHome page
A. GLUBA, M. BANACH, D. P. MIKHAILIDIS, and J. RYSZ
Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors
In Vivo, September 1, 2009; 23(5): 797 - 812.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. Dhangadamajhi, B. N. Mohapatra, S. K. Kar, and M. Ranjit
Endothelial Nitric Oxide Synthase Gene Polymorphisms and Plasmodium falciparum Infection in Indian Adults
Infect. Immun., July 1, 2009; 77(7): 2943 - 2947.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Sen, M. Demirturk, N. Abaci, E. Golcuk, H. Oflaz, A. Elitok, F. Kutluturk, H. Issever, N. E. Unaltuna, and N. C. Ozbey
Endothelial nitric oxide synthase intron 4a/b polymorphism and early atherosclerotic changes in hypopituitary GH-deficient adult patients
Eur. J. Endocrinol., May 1, 2008; 158(5): 615 - 622.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M. Pertovaara, J. Antonen, and M. Hurme
Endothelial nitric oxide synthase +894 polymorphism is associated with recurrent salivary gland swelling and early onset in patients with primary Sjogren's syndrome
Ann Rheum Dis, October 1, 2007; 66(10): 1400 - 1401.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani
Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review
Am. J. Epidemiol., November 15, 2006; 164(10): 921 - 935.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. M. Garland, R. Winker, S. M. Williams, L. Jiang, K. Stanton, D. W. Byrne, I. Biaggioni, I. Cascorbi, J. A. Phillips III, P. A. Harris, et al.
Endothelial NO Synthase Polymorphisms and Postural Tachycardia Syndrome
Hypertension, November 1, 2005; 46(5): 1103 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. A. Mansoor, O. Kristensen, T. Hervig, J. A. Stakkestad, T. Berge, P. A. Drablos, S. Rolfsen, and T. Wentzel-Larsen
Relationship between Serum Folate and Plasma Nitrate Concentrations: Possible Clinical Implications
Clin. Chem., July 1, 2005; 51(7): 1266 - 1268.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Sugita, M. Fujimoto, T. Yasukawa, N. Shimizu, M. Sugita, S. Yasuhara, J. A. J. Martyn, and M. Kaneki
Inducible Nitric-oxide Synthase and NO Donor Induce Insulin Receptor Substrate-1 Degradation in Skeletal Muscle Cells
J. Biol. Chem., April 8, 2005; 280(14): 14203 - 14211.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Malhotra, J. Poole, H. Davis, Y. Dong, J. Pollock, H. Snieder, and F. Treiber
Effects of NOS3 Glu298Asp Polymorphism on Hemodynamic Reactivity to Stress: Influences of Ethnicity and Obesity
Hypertension, December 1, 2004; 44(6): 866 - 871.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. P. Casas, L. E. Bautista, S. E. Humphries, and A. D. Hingorani
Endothelial Nitric Oxide Synthase Genotype and Ischemic Heart Disease: Meta-Analysis of 26 Studies Involving 23028 Subjects
Circulation, March 23, 2004; 109(11): 1359 - 1365.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K-W Park, K-H You, S Oh, I-H Chae, H-S Kim, B-H Oh, M-M Lee, and Y-B Park
Association of endothelial constitutive nitric oxide synthase gene polymorphism with acute coronary syndrome in Koreans
Heart, March 1, 2004; 90(3): 282 - 285.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Song, Y. Yoon, K. U. Park, J. Park, Y. J. Hong, S. H. Hong, and J. Q. Kim
Genotype-specific Influence on Nitric Oxide Synthase Gene Expression, Protein Concentrations, and Enzyme Activity in Cultured Human Endothelial Cells
Clin. Chem., June 1, 2003; 49(6): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. S. Brown, L. A.J. Kluijtmans, I. S. Young, J. Woodside, J. W.G. Yarnell, D. McMaster, L. Murray, A. E. Evans, C. A. Boreham, H. McNulty, et al.
Genetic Evidence That Nitric Oxide Modulates Homocysteine: The NOS3 894TT Genotype Is a Risk Factor for Hyperhomocystenemia
Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Grasemann, K. S. van's Gravesande, R. Buscher, N. Knauer, E. S. Silverman, L. J. Palmer, J. M. Drazen, and F. Ratjen
Endothelial Nitric Oxide Synthase Variants in Cystic Fibrosis Lung Disease
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 390 - 394.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Kimura, T. Yokoyama, Y. Matsumura, N. Yoshiike, C. Date, M. Muramatsu, and H. Tanaka
NOS3 Genotype-Dependent Correlation Between Blood Pressure and Physical Activity
Hypertension, February 1, 2003; 41(2): 355 - 360.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Correction
Yeomin Yoon
Clinical Chemistry Online, 13 Dec 2000 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.